Your browser is no longer supported. Please, upgrade your browser.
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-3.45 Insider Own0.10% Shs Outstand28.92M Perf Week-11.83%
Market Cap648.68M Forward P/E- EPS next Y-2.57 Insider Trans0.00% Shs Float28.75M Perf Month19.25%
Income-90.70M PEG- EPS next Q-0.95 Inst Own72.00% Short Float22.16% Perf Quarter37.44%
Sales11.00M P/S58.97 EPS this Y9.90% Inst Trans18.99% Short Ratio14.85 Perf Half Y53.63%
Book/sh3.82 P/B5.87 EPS next Y33.60% ROA-55.60% Target Price38.20 Perf Year24.06%
Cash/sh4.24 P/C5.29 EPS next 5Y- ROE-66.40% 52W Range12.50 - 26.89 Perf YTD33.04%
Dividend- P/FCF- EPS past 5Y14.50% ROI-82.90% 52W High-16.59% Beta2.45
Dividend %- Quick Ratio6.30 Sales past 5Y-22.90% Gross Margin- 52W Low79.44% ATR1.26
Employees197 Current Ratio6.30 Sales Q/Q-17.90% Oper. Margin- RSI (14)54.50 Volatility5.99% 5.95%
OptionableYes Debt/Eq0.10 EPS Q/Q6.60% Profit Margin- Rel Volume1.61 Prev Close23.14
ShortableYes LT Debt/Eq0.10 EarningsMar 05 BMO Payout- Avg Volume429.06K Price22.43
Recom1.60 SMA20-0.36% SMA5015.92% SMA20038.76% Volume678,766 Change-3.07%
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Nov-16-12Reiterated MLV & Co Buy $10 → $7.50
Jan-04-12Initiated MLV & Co Buy $8
Nov-09-10Reiterated Wedbush Outperform $6 → $8
Nov-08-10Initiated Jefferies Buy $4
May-13-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
Mar-20-09Initiated Wedbush Morgan Buy $1.20
Oct-22-08Downgrade Oppenheimer Outperform → Perform
May-19-08Reiterated Susquehanna Financial Positive $7 → $5
May-19-08Downgrade Bear Stearns Outperform → Peer Perform
Mar-18-08Downgrade Merriman Curhan Ford Buy → Neutral
Feb-22-08Upgrade Oppenheimer Perform → Outperform $8.50
Oct-03-07Initiated Credit Suisse Outperform $8
Jun-06-07Initiated Susquehanna Financial Positive
Feb-26-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
Mar-26-15 07:33PM  Lightning Round: This was a 'one and done' at CNBC -5.85%
07:13PM  Cramer Remix: I'm making a call on oil unrest at CNBC
Mar-25-15 06:04PM  Nasdaq stocks posting largest percentage increases AP -6.60%
Mar-23-15 12:13PM  ICYMI: Pharmaceutical Stocks Are Moving Big On Monday +10.79%
09:16AM  Stock Futures Aim Mildly Lower; Dollar Dips, Tenet Jumps On JV at Investor's Business Daily
Mar-19-15 10:46AM  Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference at noodls
10:46AM  Dynavax to Present at the 2015 RBC Capital Markets' Global Healthcare Conference at noodls
10:46AM  Dynavax Reports Fourth Quarter and Year End 2014 Financial Results at noodls
10:46AM  Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) at noodls
Mar-16-15 07:27AM  Dynavax Technologies (DVAX) Shares March Higher, Can It Continue? - Tale of the Tape
Mar-13-15 01:04PM  DYNAVAX TECHNOLOGIES CORP Financials
Mar-07-15 07:08PM  10-K for Dynavax Technologies Corp. at Company Spotlight
Mar-05-15 05:19PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
05:11PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report
06:48AM  Dynavax Technologies reports 4Q loss
06:00AM  Dynavax Reports Fourth Quarter and Year End 2014 Financial Results Marketwired
Mar-02-15 06:00AM  Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) Marketwired +6.87%
Feb-27-15 04:59PM  Dynavax to Present at the Cowen and Company 35th Annual Health Care Conference Marketwired
Feb-19-15 04:15PM  Dynavax to Present at the 2015 RBC Capital Markets' Global Healthcare Conference Marketwired
Feb-11-15 04:39PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh EDGAR Online
Feb-06-15 09:00AM  Dynavax Announces Laura Brege Has Joined Board of Directors and Denise Gilbert Will Retire Marketwired
Jan-12-15 04:05PM  Dynavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference Marketwired
Jan-09-15 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Dec-29-14 06:18AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financ EDGAR Online
06:00AM  Dynavax Secures $40 Million Credit Facility With Hercules Technology Growth Capital Marketwired
Dec-09-14 05:20PM  Dynavax & AstraZeneca Alter Agreement for Asthma Product Zacks
06:00AM  Dynavax Announces Webcast of R&D Day Marketwired
Dec-08-14 04:14PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex EDGAR Online
12:31PM  Best biotech trades on ASH meeting: Kensho at CNBC
06:00AM  Dynavax and AstraZeneca to Advance TLR9 Agonist for Treatment of Asthma Into Phase 2a Clinical Study Marketwired
Dec-01-14 04:20PM  Dynavax Regains TLR 7/9 Inhibitor DV1179 Rights from Glaxo Zacks -5.18%
Nov-28-14 06:18AM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:00AM  Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Collaboration With GSK Marketwired
Nov-21-14 10:07PM  Lightning Round: You're playing with fire at CNBC
Nov-11-14 04:30PM  Dynavax's Heplisav Phase III Trial Recommended to Continue Zacks
Nov-10-14 04:33PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material D EDGAR Online
06:00AM  Dynavax Announces Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) Marketwired
Nov-07-14 07:08PM  10-Q for Dynavax Technologies Corp. Company Spotlight
05:05PM  Dynavax Announces One-for-Ten Reverse Stock Split Marketwired
Nov-05-14 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:07PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06:18AM  Dynavax Technologies misses 3Q profit forecasts AP
06:00AM  Dynavax Reports Third Quarter 2014 Financial Results Marketwired
Oct-27-14 08:06AM  Dynavax Technologies (DVAX) Shares March Higher, Can It Continue? Zacks
Oct-14-14 04:12PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.07%
03:45PM  Dynavax Initiates Phase I/II Trial on Lymphoma Candidate Zacks
Oct-13-14 06:00AM  Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma Marketwired
Oct-07-14 04:04PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:00PM  Dynavax Announces Resignation of Dino Dina From Board of Directors Marketwired
Sep-23-14 04:00PM  Dynavax (DVAX) Completes Enrolment for Study on Heplisav Zacks
Sep-22-14 04:15PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:49AM  Dynavax (DVAX) Jumps: Stock Moves 6.7% Higher Zacks
06:00AM  Dynavax Completes Enrollment of Phase 3 Study of HEPLISAV-B(TM) Marketwired
Aug-08-14 04:10PM  Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat Zacks
Aug-07-14 04:30PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online -5.26%
04:17PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06:00AM  Dynavax Reports Second Quarter 2014 Financial Results and Safety and Pharmacodynamic Results for Asthma and Lupus Drug Candidates Marketwired
Jul-30-14 08:01AM  Dynavax Technologies (DVAX) Jumps: Stock Gains 6.4% Zacks
Jul-04-14 07:52AM  Better Buy: Dynavax Technologies Corp. vs. Geron Corp. at Motley Fool
Jun-18-14 08:35AM  Will Dynavax (DVAX) Continue to Surge Higher? Zacks
Jun-09-14 04:00PM  Dynavax to Present at the William Blair 2014 Growth Stock Conference Marketwired
Jun-06-14 01:15PM  2 Small-Cap Biotechs for Your Watchlist at Motley Fool
Jun-02-14 04:00PM  Dynavax to Present at the Jefferies Global Healthcare Conference Marketwired
May-29-14 04:16PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V EDGAR Online
May-27-14 08:35AM  Dynavax (DVAX) Sees Hammer Chart Pattern: Time to Buy? Zacks
May-08-14 06:32PM  Why Dynavax Technologies Corporation Should Be on Your Watchlist at Motley Fool -12.16%
May-06-14 10:50AM  Dynavax Reports In Line Q1 Results Zacks -7.01%
May-05-14 04:46PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:31PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
09:00AM  Dynavax Reports First Quarter 2014 Financial Results Marketwired
Apr-30-14 06:00PM  Five Small Biotech Stocks Analysts Think Will Triple at Forbes
Apr-24-14 07:06AM  Ambit Biosciences Slumps: AMBI Falls 7.1% in Session Zacks
Apr-17-14 06:51AM  What Falling Estimates & Price Mean for Discovery Laboratories (DSCO) Zacks
Apr-16-14 04:30PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
03:10PM  Dynavax Starts Phase III Study on Heplisav-B Zacks
Apr-15-14 09:44AM  Tuesdays Top Health Care Stories: Johnson & Johnson, Teva, Mylan, and Dynavax at Motley Fool
06:00AM  Dynavax Initiates Phase 3 Study of HEPLISAV-B(TM) Marketwired
Mar-21-14 06:31PM  Does Mannkind Offer a Good Risk to Reward Ratio? at Motley Fool
Mar-13-14 11:00AM  4 Health Care Stocks With More Than 100% Upside StreetAuthority Network
Mar-11-14 08:10AM  Wider Q4 Loss at Dynavax Zacks
Mar-10-14 04:37PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:14PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report EDGAR Online
04:00PM  Dynavax Reports Fourth Quarter and Year End 2013 Financial Results Marketwired
Mar-07-14 05:45PM  Scandal-Ridden SAC Capital Buys Broadcom, Dynavax, and Boston Scientific at Motley Fool
Mar-06-14 08:20AM  Will Dynavax (DVAX) Continue to Surge Higher? Zacks -5.39%
Mar-05-14 02:59PM  Dynavax: An Update On This Speculative $2 Biotech Play at Seeking Alpha
10:40AM  Dynavax Receives Milestone Payments from AstraZeneca Zacks
Mar-04-14 04:45PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online +5.29%
Mar-03-14 04:00PM  Dynavax to Receive $5.4 Million Milestone Marketwired
Feb-28-14 04:00PM  Dynavax to Present at the 34th Annual Cowen & Company Health Care Conference Marketwired
Feb-20-14 05:20PM  Dynavax Withdraws MAA on Heplisav Zacks
Feb-18-14 04:47PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02:31PM  3 Biotech Stocks with Great Upside: Inovio Pharmaceuticals, Dynavax, and Ariad at Motley Fool
10:00AM  Dynavax withdraws EU marketing application for Hep B vaccine Reuters
09:00AM  Dynavax Announces Withdrawal of European Marketing Application for HEPLISAV(TM) Marketwired
Feb-12-14 03:45PM  Tekmira Announces New Appointment to Board of Directors GlobeNewswire
Feb-07-14 04:52PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jan-21-14 01:53PM  A Glimpse At Our Small Cap Biotechnology Portfolio at Seeking Alpha -5.31%
Jan-19-14 09:19AM  3 Good Speculative Stocks For Under $3 A Share at Seeking Alpha
Jan-10-14 05:00PM  Dynavax to Present at the 32nd Annual J.P. Morgan Healthcare Conference Marketwired
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. It development programs focus on the areas of vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. The company's product pipeline includes HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; SD-101, a CpG TLR9 agonist for the treatment of cancer immunotherapy that is in Phase I/II clinical trials; AZD1419, a drug candidate for the treatment of asthma, which has completed Phase I trial; DV1179, a TLR7/9 inhibitor that is in Phase I clinical trial for autoimmune or inflammatory conditions; and DV230-Nanoparticle, a second generation adjuvant that is in preclinical studies. It has a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease; and strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gray EddieCEO and DirectorAug 14Buy1.4925,00037,25025,000Aug 14 04:18 PM